Balancing Bleeding and Thrombosis in Lung Adenocarcinoma – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Thomas Fusillo et al. published in JTH, adding:
“Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and VEGF or EGFR inhibitors
Clinicians often worry about combining anticoagulation with targeted cancer drugs.
In patients with lung adenocarcinoma, giving anticoagulants alongside VEGF or EGFR inhibitors was not associated with a statistically significant rise in major or clinically relevant non-major bleeding.
The data offer some reassurance for treating thrombosis in this group, though careful patient selection still applies.”
Title: Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors
Authors: Thomas F. Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach, Adam Schoenfeld, Rohan Singh, Peter Kaplinsky, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026